Table 1.
Hypertriglyceridemia | |
---|---|
Primary | Secondary |
Familial hyperchylomicronemia (type 1) Lipoprotein lipase (LPL) deficiency or mutations in genes regulating the catabolism of triglyceride-rich-lipoproteins (APOC2, APOA5, GPIHBP1, LMF1, GPD1) |
Obesity Diabetes mellitus (especially when undiagnosed or uncontrolled) Metabolic syndrome components may have genetic susceptibility |
Familial combined hyperlipidemia (type 2b; multygenic) | Hypothyroidism |
Familial dysbetalipoproteinemia (type 3; APO-E mutations) | Excessive alcohol intake |
Familial hypertriglyceridemia (type 4) Mixed Hypertriglyceridemia (type 5; multigenic) |
High glycemic index or saturated fat diet, with excessive energy intake |
Rare genetic diseases: familial partial lipodystrophy | Drugs (Thiazides, non-selective beta-blockers, estrogens, tamoxifen, bile-acids resins, corticosteroids, protease inhibitors, cyclosporine, retinoids, anti-epileptics, antipsychotics, etc.) |
Pregnancy | |
Cushing’s syndrome | |
Autoimmune conditions | |
Advanced renal disease/nephrotic syndrome | |
Advanced liver disease |